Searching for your content...
Phone
877-269-7890 from 8 AM - 10 PM ET
Contact Cision
VANCOUVER, Aug. 5, 2014 /CNW Telbec/ - On July 30, 2014, Merck was advised by the British Columbia Medical Beneficiary and Pharmaceutical Services Division of the delisting of all sitagliptin...
Runny nose; sneezing; itchy nose, throat, or eyes; and congestion: An estimated 20% to 25% of the Canadian population suffer from allergic rhinitis1 KIRKLAND, QC, May 15, 2014 /CNW Telbec/ - A new...
An estimated 20% to 25% of the Canadian population suffer from allergic rhinitis1 KIRKLAND, QC, Feb. 3, 2014 /CNW Telbec/ - A new treatment option is now available for Canadian allergic rhinitis...
Nasal irrigation with seawater gains popularity as an effective way to relieve cold-induced nasal and sinus symptoms, and prevent illness for the whole family TORONTO, Jan. 15, 2014 /CNW/ - Every...
Sustained virologic response at post-treatment follow-up week 12 (SVR 12) seen in 100 per cent of patients to date in two of the three combination arms studied MONTREAL, Nov. 2, 2013 /CNW/ - Merck...
MONTREAL, Oct. 7, 2013 /CNW/ - Results from two new studies add to the body of evidence that supports CognigramTM as a sensitive assessment to detect and monitor cognitive decline over time, namely...
QUEBEC CITY, Oct. 3, 2013 /CNW Telbec/ - At an announcement made earlier today, at the BioContact Quebec Biopharmaceutical Partnership Symposium, Merck Canada confirmed its commitment to the Quebec...
These multi-million dollar grants will be used to enhance the academic research environment at four Quebec Universities QUEBEC CITY, Oct. 2, 2013 /CNW Telbec/ - Members of the media are invited to a...
SHERBROOKE, QC, Sept. 27, 2013 /CNW Telbec/ - Merck Canada announced at the Sherbrooke International Life Sciences Summit that it is reinforcing its commitment to the Quebec life sciences research...
Join one of Canada's top R&D investors on Friday, September 27 during the Sherbrooke International Life Sciences Summit SHERBROOKE, QC, Sept. 25, 2013 /CNW Telbec/ - Members of the media are invited...
MONTREAL, July 17, 2013 /CNW/ - New data provided evidence of a useful new tool in the detection and monitoring of cognitive impairment in aging and dementia. The data showed the clinical utility of...
A $4-million public-private partnership will promote research innovation involving three academic commercialization centres in Canada CHICAGO, ILLINOIS, April 22, 2013 /CNW Telbec/ - Merck Canada...
CHICOUTIMI, QC, April 18, 2013 /CNW Telbec/ - Merck is proud to once again be a partner of the Super Expo-sciences Hydro-Québec provincial final, whose 2013 edition starts today at Chicoutimi's Zone...
KIRKLAND, QC, Jan. 15, 2013 /CNW Telbec/ - Despite significant therapeutic advances in the treatment of HIV/AIDS in Canada and around the world, treating children with HIV can be especially...
A $12.5 million contribution will fund academic and hospital-affiliated research institutions KIRKLAND, QC, Nov. 26, 2012 /CNW Telbec/ - Merck Canada announced today that it is reinforcing its...
Join one of Canada's top R&D investors on Monday, November 26, at the Centre Sheraton Montréal KIRKLAND, QC, Nov. 22, 2012 /CNW Telbec/ - Members of the media are invited to attend a press conference ...
Merck's hepatitis C treatment receives prestigious Innovative Product Award KIRKLAND, QC, Nov. 15, 2012 /CNW/ - Merck is proud to announce that VICTRELIS™ (boceprevir), a first-in-class oral...
KIRKLAND, QC, Nov. 12, 2012 /CNW Telbec/ - Merck is pleased to announce a grant of $500,000 to the Centre de coopération internationale en santé et développement (Center for International Cooperation ...
BOSTON, MA, Nov. 10, 2012 /CNW/ - Merck announced interim results from a Phase II, multi-center, randomized, dose-ranging study (n=332) assessing the safety and antiviral activity of MK-5172, an...
Strengthened commitment to Kirkland with head office relocation to new LEED-certified, best-in-class facilities KIRKLAND, QC, Nov. 1, 2012 /CNW Telbec/ - Merck Canada is pleased to announce that it...
Join PR Newswire for Journalists to access all of the free services designated to make your job easier.
In need of subject matter experts for your story? Submit a free ProfNet request and find the sources you need.